Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.
作者信息
Chhetri Rakchha, Wee Li Yan A, Sinha Romi, Kutyna Monika M, Pham Anh, Stathopoulos Helen, Nath Lakshmi, Nath Shriram V, Wickham Nicholas, Hughes Tim, Singhal Deepak, Roxby David J, Hiwase Devendra K
机构信息
Haematology Department, Royal Adelaide Hospital, Central Adelaide Local Health Network.
Precision Medicine, South Australian Health and Medical Research Institute.
出版信息
Haematologica. 2019 Oct;104(10):e451-e454. doi: 10.3324/haematol.2018.215087. Epub 2019 Feb 28.
Abstract
摘要
相似文献
1
Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.骨髓增生异常综合征中的红细胞自身免疫和同种免疫：患病率、特征及意义。
Haematologica. 2019 Oct;104(10):e451-e454. doi: 10.3324/haematol.2018.215087. Epub 2019 Feb 28.
2
Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.在受体流行病学和供者评估研究（REDS-III）数据库中，红细胞同种免疫的危险因素。
Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.
3
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.红细胞同种免疫与骨髓增生异常综合征自身抗体的产生和红细胞输注需求增加有关。
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
4
[Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].[112例骨髓增生异常综合征患者的免疫血液学研究：10年分析]
Sangre (Barc). 1995 Jun;40(3):177-80.
5
Red blood cell alloimmunization: lessons from sickle cell disease.红细胞同种免疫：镰状细胞病的经验教训
Transfusion. 2013 Apr;53(4):692-5. doi: 10.1111/trf.12146.
6
Clinical Utility of Flow Cytometry for Detection of Anti-Jk IgM in Acute Haemolytic Transfusion Reaction.流式细胞术检测急性溶血性输血反应抗 Jk（b）IgM 的临床应用
Intern Med. 2024 May 1;63(9):1273-1275. doi: 10.2169/internalmedicine.2639-23. Epub 2023 Sep 29.
7
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.预防性RhCE和凯尔抗原配型：对依赖输血的骨髓增生异常综合征患者同种免疫的影响
Vox Sang. 2017 Jan;112(1):79-86. doi: 10.1111/vox.12455. Epub 2016 Oct 19.
8
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.输血治疗骨髓增生异常综合征或慢性粒单核细胞白血病患者的红细胞同种免疫。
Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.
9
Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.三级医院中多次输血的儿科患者的红细胞同种免疫。
Indian J Pediatr. 2019 Mar;86(3):245-249. doi: 10.1007/s12098-018-2815-9. Epub 2018 Dec 4.
10
Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.阿扎胞苷对骨髓增生异常综合征患者红细胞同种免疫的影响。
Blood Transfus. 2017 Sep;15(5):472-477. doi: 10.2450/2016.0012-16. Epub 2016 Jun 24.
引用本文的文献
1
How I treat anemia with red blood cell transfusion and iron.我如何用红细胞输血和铁剂治疗贫血。
Blood. 2023 Aug 31;142(9):777-785. doi: 10.1182/blood.2022018521.
2
Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.体细胞突变与新发或治疗相关骨髓增生异常综合征中的红细胞或人类白细胞抗原同种免疫无明显关联。
Transfusion. 2022 Dec;62(12):2470-2479. doi: 10.1111/trf.17155. Epub 2022 Oct 24.
3
A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based study.输血治疗骨髓增生异常综合征患者的疾病修饰治疗对同种免疫的临床疗效：基于人群的研究数据。
Blood Transfus. 2022 Jan;20(1):18-26. doi: 10.2450/2020.0168-20. Epub 2020 Dec 16.
4
Outpatient transfusions for myelodysplastic syndromes.骨髓增生异常综合征的门诊输血治疗。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):167-174. doi: 10.1182/hematology.2020000103.
本文引用的文献
1
Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of Minas Gerais.米纳斯吉拉斯州一个血液中心针对红细胞抗原发生同种免疫和自身免疫的多次输血患者的临床和流行病学概况。
Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):107-111. doi: 10.1016/j.htct.2017.08.001. Epub 2018 Feb 17.
2
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.红细胞同种免疫与骨髓增生异常综合征自身抗体的产生和红细胞输注需求增加有关。
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
3
Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.Rh和K的分子匹配可降低骨髓增生异常综合征患者的红细胞同种免疫。
Blood Transfus. 2015 Jan;13(1):53-8. doi: 10.2450/2014.0332-13. Epub 2014 Jun 12.
4
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.输血治疗骨髓增生异常综合征或慢性粒单核细胞白血病患者的红细胞同种免疫。
Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.
5
Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.红细胞同种免疫反应者和无反应者小鼠体内调节性T细胞的状态
Blood. 2009 May 28;113(22):5624-7. doi: 10.1182/blood-2008-12-193748. Epub 2009 Mar 31.
6
Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.输血导致的红细胞自身抗体与同种抗体共存。
Transfusion. 2007 May;47(5):813-6. doi: 10.1111/j.1537-2995.2007.01194.x.
7
Warm reactive autoantibodies: clinical and serologic correlations.温反应性自身抗体：临床与血清学相关性
Am J Clin Pathol. 2004 Nov;122(5):680-5. doi: 10.1309/CJAW-6N8J-6H0H-R2WM.
8
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?同种免疫后自身抗体的形成：输血是自身免疫性溶血性贫血的危险因素吗？
Transfusion. 2004 Jan;44(1):67-72. doi: 10.1046/j.0041-1132.2003.00589.x.
9
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen.白细胞介素-10介导的调节性T细胞对人红细胞自身抗原表位的应答。
Blood. 2002 Dec 15;100(13):4529-36. doi: 10.1182/blood-2002-05-1383. Epub 2002 Aug 1.
10
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.接受输血的镰状细胞病患者中红细胞同种抗体和自身抗体的临床意义。
Transfusion. 2002 Jan;42(1):37-43. doi: 10.1046/j.1537-2995.2002.00007.x.
Zotero 插件